Efek Neuroprotektor Kunyit pada Pasien Alzheimer
DOI:
https://doi.org/10.32584/jikj.v2i3.431Keywords:
Alzheimer, Curcuma longa L, Neuroprotektor, Anti Agregasi Aβ, Protein Tau, β secretase inhibitorAbstract
Alzheimer merupakan penyakit neurogeneratif kronis progresif. Penyakit ini ditandai dengan gangguan fungsi luhur seperti bahasa, kalkulasi, kapasitas belajar dan sulit mengambil keputusan. ‘Pikun’ merupakan istilah yang digunakan masyarakat untuk menggambarkan penyakit ini. Kehilangan memori jangka pendek merupakan kekhasan dari penyakit ini yang menyebabkan penurunkan produktivitas. Alzheimer sering terjadi pada usia > 65 tahun dan juga ditemukan pada sekitar usia 40 tahun. Kunyit (Curcuma longa L.) merupakan tanaman yang berfungsi sebagai neuroprotektor karena dapat menghambat Protein Tau, akivitas asetilkolinesterase dan berfungsi sebagai anti agregasi Aβ dan β secretase inhibitor. Literature review ini bertujuan untuk menjelaskan gambaran efek neuroprotektor pada kunyit terhadap pasien Alzheimer yang sudah dilakukan oleh peneliti sebelumnya. Metode yang digunakan dalam artikel ini adalah penelusuran artikel melalui database NCBI dan Google Scholar. Tahun penerbitan sumber pustaka adalah dari tahun 2001 sampai 2019 dengan 32 sumber pustaka.Tema dalam artikel yang dikumpulkan yaitu terkait gambaran efek neuroprotektor kunyit terhadap pasien Alzheimer. Hasil dari sintesa artikel yang telah ditemukan yaitu kunyit dapat mencegah penurunan kognitif pada pasien Alzheimer. Kata kunci : Alzheimer, Kunyit, Neuroprotektor EFFECT OF NEUROPROTECTOR TURMERIC ON ALZHEIMER’S PATIENTS ABSTRACT Alzheimer's is a chronic progressive neurogenerative disease. This disease is characterized by impaired noble functions such as language, calculations, learning capacity and difficulty making decisions. ‘Pikun’ is a word used by the community to describe this disease. Short-term memory loss is a spesific sign in the patient, this disease causes decrease in productivity. Alzheimer's often occurs at age> 65 years and is also found at around the age of 40 years. Turmeric (Curcuma longa L.) is a plant that functions as a neuroprotector because it can inhibit Tau Proteins, acetylcholinesterase activity and function as anti-aggregation Aβ and β secretase inhibitors. This literature review aims to explain the description of the effects of neuroprotector on turmeric on Alzheimer's patients that have been done by previous researchers. The method used in this article is the search of articles through the NCBI and Google Scholar databases. The themes in the articles collected are related to the description of the effects of turmeric neuroprotector on Alzheimer's patients. The year of publication of library sources is from 2001 to 2019 with 32 library sources. The results of various articles included in this article are turmeric can prevent cognitive decline in Alzheimer's patients. Keywords: Alzheimer's,Turmeric, neuroprotectorReferences
Alloza, M. G., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007). Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal OfNeurochemistry, 102, 1095–1104. https://doi.org/10.1111/j.1471-4159.2007.04613.x
Alzheimer’s Association. (2007). Alzheimer’s Disease Facts and Figures. Retrieved from https://www.alz.org/national/documents/Report_2007FactsAndFigures.pdf
Baum, L., & Ng, A. (2004). Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. Journal of Alzheimer’s Disease, 6, 367–377. https://doi.org/10.3233/jad-2004-6403
Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., & Banerjee, R. K. (2004). Turmeric and curcumin : Biological actions and medicinal applications. CURRENT SCIENCE, 87(1), 44–53.
Clodomiro, A., Gareri, P., Puccio, G., Frangipane, F., Lacava, R., Castagna, A., … Cecilia, A. (2013). Somatic comorbidities and Alzheimer ’ s disease treatment, 1581–1589. https://doi.org/10.1007/s10072-013-1290-3
Cole, G. M., Teter, B., & Frautschy, S. A. (2007). NEUROPROTECTIVE EFFECTS OF CURCUMIN. Adv Exp Med Biol, 595, 197–212.
Fiala, M., Liu, P. T., Espinosa-jeffrey, A., Rosenthal, M. J., Bernard, G., Ringman, J. M., … Cashman, J. (2007). Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer’s disease patients are improved by bisdemethoxycurcumin. PNAS, 104(31), 12849–12854. https://doi.org/10.1073/pnas.0701267104
Goozee, K. G. (2013). McCusker KARVIAH: Curcumin in Alzheimer’s disease prevention. Retrieved from https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000681752.
Hamaguchi, T., Ono, K., & Yamada, M. (2010). Curcumin and Alzheimer ’ s Disease, 16, 285–297. https://doi.org/10.1111/j.1755-5949.2010.00147.x
Hishikawa, N., Takahashi, Y., Amakusa, Y., Tanno, Y., & Tuji, Y. (2012). Effects of turmeric on Alzheimer ’ s disease with behavioral and psychological symptoms of dementia. AYU, 33(4), 499–504. https://doi.org/10.4103/0974-8520.110524
Jiang, J., Wang, W., Sun, Y. J., Hu, M., Li, F., & Zhu, D. Y. (2007). Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood – brain barrier damage. European Journal of Pharmacology, 561, 54–62. https://doi.org/10.1016/j.ejphar.2006.12.028
Kementerian Kesehatan RI. (2016). Peran Keluarga Dukung Kesehatan Masyarakat. Kementrian Kesehatan RI, 1–2. Retrieved from http://www.depkes.go.id/article/print/16100700005/peran-keluarga-dukung-kesehatan-jiwa-masyarakat.html
Kementerian Kesehatan RI. (2018). Lansia Sejahtera, Masyarakat Bahagia. Kementerian Kesehatan RI, 1–2. Retrieved from www.depkes.go.id/article/view/18050900001/lansia-sejahtera masyarakat%0A bahagia-.html%0A
Kennedy, R. E., Cutter, G. R., Fowler, M. E., & Schneider, L. S. (2018). Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials, 1(7), 1–10. https://doi.org/10.1001/jamanetworkopen.2018.4080
Kim, D. S. H. L., Park, S., & Kim, J. (2001). Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA (1-42) insult. Neuroscience Letters, 303, 57–61. https://doi.org/10.1016/s0304-3940(01)01677-9
Kumar, A., & Tsao, J. W. (2019). Alzheimer Disease. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK499922/
Lao, C. D., Iv, M. T. R., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., … Brenner, D. E. (2006). BMC Complementary and Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine, 6(10), 4–7. https://doi.org/10.1186/1472-6882-6-10
Lewis, J., Lewis, J., Dickson, D. W., Lin, W., Chisholm, L., Corral, A., … Mcgowan, E. (2001). Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP. SCIENCE, 293, 1487–1491. https://doi.org/10.1126/science.1058189
Lin, R., Chen, X., Li, W., Han, Y., Liu, P., & Pi, R. (2008). Neuroscience Letters Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells : Blockage by curcumin. Neuroscience Letters, 440, 344–347. https://doi.org/10.1016/j.neulet.2008.05.070
Ma, Q., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., … Cole, G. M. (2009).  -Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling : Suppression by Omega-3 Fatty Acids and Curcumin, 29(28), 9078–9089. https://doi.org/10.1523/JNEUROSCI.1071-09.2009
Noviria, M., Triyoso, & Yanti, L. (2014). HUBUNGAN DUKUNGAN KELUARGA DENGAN KUNJUNGAN KONTROLPASIEN JIWA. JURNAL KESEHATAN HOLISTIK, 8(2), 76–81.
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004). Curcumin Has Potent Anti-Amyloidogenic Effects for Alzheimer ’ s  -Amyloid Fibrils In Vitro, 750, 742–750.
Park, S., & Kim, D. S. H. L. (2002). Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult : A Drug Discovery Effort against Alzheimer’s Disease. Journal of Natural Products, 65(9), 1227–1231. https://doi.org/10.1021/np010039x
Reddy, P. H., Manczak, M., & Mitchell, A. (2018). HHS Public Access Author manuscript, (October). https://doi.org/10.3233/JAD-170512
Shukla, P. K., Khanna, V. K., Khan, M. Y., & Srimal, R. C. (2003). Protective effect of curcumin against lead neurotoxicity in rat. Human & Experimental Toxicology, 22, 653–658. https://doi.org/10.1191/0960327103ht411oa
Valasani, K. R., Sun, Q., Hu, G., Li, J., Du, F., & Guo, Y. (2014). Identification of Human ABAD Inhibitors for Rescuing Aβ- Mediated Mitochondrial Dysfunction. Curr Alzheimer Res, 11(2), 128–136. https://doi.org/10.2174/1567205011666140130150108
Videbeck, S. L. (2008). Buku Ajar Keperawatan Jiwa. Jakarta: EGC.
Villaflores, O. B., Chen, Y., Chen, C., & Yeh, J. (2012). Curcuminoids and resveratrol as anti-Alzheimer agents. Taiwanese Journal of Obstetrics & Gynecology, 51(4), 515–525. https://doi.org/10.1016/j.tjog.2012.09.005
Yang, F., Lim, G. P., Aynun, N., Ubeda, O. J., Mychica, R., Ambegaokar, S. S., … Cole, G. M. (2005). Protein Structure and Folding : Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils , Binds Plaques , and Reduces Amyloid in Vivo Curcumin Inhibits Formation of Amyloid  Oligomers and Fibrils , Binds Plaques , and Reduces Amyloid in Vivo *. https://doi.org/10.1074/jbc.M404751200
Zhang, L., Fang, Y., Xu, Y., Lian, Y., Xie, N., & Wu, T. (2015). Curcumin Improves Amyloid β -Peptide ( 1-42 ) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway, 1–17. https://doi.org/10.1371/journal.pone.0131525
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution 4.0 International License.
